Literature DB >> 10393126

The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts.

D T Graves1, Y Jiang, A J Valente.   

Abstract

Chemokines are low molecular weight secretory proteins that function principally as stimulators of leukocyte recruitment. There are four defined chemokine subfamilies based on their primary structure, CXC, CC, C and CX3C. Members of the CC chemokine subfamily, a such as monocyte chemoattractant protein 1 (MCP-1) are chemotactic for monocytes and other leukocyte subsets. Because monocytes produce factors that regulate bone formation or resorption, such as PDGF, IL-1 or TNF, chemokines that initiate their recruitment are likely to be important in regulating osseous metabolism. In the studies below, data is presented demonstrating mechanisms of MCP-1 expression in osteoblastic cells. These studies establish that MCP-1 is induced during osseous inflammation and in developmentally regulated bone remodelling, and is associated with enhanced monocyte recruitment when applied to osseous lesions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393126     DOI: 10.2741/graves

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  26 in total

Review 1.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

3.  Integrin and chemokine receptor gene expression in implant-adherent cells during early osseointegration.

Authors:  Omar Omar; Maria Lennerås; Sara Svensson; Felicia Suska; Lena Emanuelsson; Jan Hall; Ulf Nannmark; Peter Thomsen
Journal:  J Mater Sci Mater Med       Date:  2009-10-25       Impact factor: 3.896

4.  Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization.

Authors:  Karen M Bussard; Noriaki Okita; Neil Sharkey; Thomas Neuberger; Andrew Webb; Andrea M Mastro
Journal:  Clin Exp Metastasis       Date:  2010-05-06       Impact factor: 5.150

5.  Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.

Authors:  Karen M Bussard; David J Venzon; Andrea M Mastro
Journal:  J Cell Biochem       Date:  2010-12-01       Impact factor: 4.429

6.  The chemokine (C-C-motif) receptor 3 (CCR3) gene is linked and associated with age at menarche in Caucasian females.

Authors:  Fang Yang; Dong-hai Xiong; Yan Guo; Hui Shen; Peng Xiao; Feng Zhang; Hui Jiang; Robert R Recker; Hong-wen Deng
Journal:  Hum Genet       Date:  2006-12-05       Impact factor: 4.132

Review 7.  Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases.

Authors:  Aimalie L Hardaway; Mackenzie K Herroon; Erandi Rajagurubandara; Izabela Podgorski
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

8.  Prolactin alters the mRNA expression of osteoblast-derived osteoclastogenic factors in osteoblast-like UMR106 cells.

Authors:  Kannikar Wongdee; Warut Tulalamba; Jirawan Thongbunchoo; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  Mol Cell Biochem       Date:  2010-11-30       Impact factor: 3.396

Review 9.  Osteoblast-osteoclast interactions.

Authors:  Xiao Chen; Zhongqiu Wang; Na Duan; Guoying Zhu; Edward M Schwarz; Chao Xie
Journal:  Connect Tissue Res       Date:  2017-03-21       Impact factor: 3.417

10.  Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp.

Authors:  M Victoria Delpino; Carlos A Fossati; Pablo C Baldi
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.